[ad_1]
Mizuho upped their price objective on Guardant Health from $65.00 to $70.00 and gave the stock an “outperform” rating in a research report on Thursday.
[ad_2]
Source link
[ad_1]
Mizuho upped their price objective on Guardant Health from $65.00 to $70.00 and gave the stock an “outperform” rating in a research report on Thursday.
[ad_2]
Source link